Decentralization is helping to shape the course of scientific research and business


New technologies may have rapid and dramatic effects on society, but they may also spread slowly and gently. The distributed science powered by blockchain (DeSci) takes off after several years of pregnancy. Its impact is felt not only within the rare confines of high-tech labs, but also in the business world more broadly.

Psychedelia and longevity

Paul Koolhaas, co-founder and CEO of Molecule – a platform for DAOs biotechnology founded in 2019 – talked about drug research and funding in the Zima Red podcast in April. “We believe it could be much cheaper if it was better coordinated,” he said. Koolhaas on drug research. “I think there is a cultural and bureaucratic problem.”

Kohlhaas compared blockchain in pharma to fintech in banking. “The banking industry has only started to develop in the last ten years following the fintech, because the fintech is really starting to hit their bottom line and take out customers,” he said.

Molecule enables researchers, biotechnology companies and universities to combine information rights and intellectual property (IP) for non-IP tokens (IP-NFT), thus creating a new market. The IP-NFT holder can request funding for further research activities, or an organization can reach an agreement with the IP-NTF holder to use the data and IP for its own purposes.

Funding may also find new points. Koolhaas mentioned the study of psychedelia in psychiatry as a top priority that he personally adopts, as well as longevity. “Longevity start-ups are currently funded by billionaires,” he said. “But I think there is a risk there. Because if like the richest people in the world they live more and more and get richer and richer, it is fundamentally, in the long run, creating an unjust society, because wealth is not distributed.”

Related: The crypto world needs to know about longevity

Research Hub is an open-access research platform that Chief Operating Officer Patrick Joyce has compared to GitHub for scientific research. Joyce told the Cointelegraph that the platform, backed by Coinbase CEO Brian Armstrong, could ultimately provide a serious incentive for open access advertising and research funding on topics that the National Science Foundation does not fund, such as quantum biology.

Businesses get blockchain reinforcement

DeSci can provide an advantage in the number of commercial contexts. The dense field of consumer genomics is an example of this. Genomes.io, based in London, offers the public 30x a complete genome sequence. This is in contrast to more well-known brands that sequence only the genetic axum, passing over โ€œjunkโ€ genes that make up the vast majority of the genome and their importance is quickly revealed. “Not a week goes by without a discovery,” Aldo de Papa, CEO and co-founder of Genomes.io, told Cointelegraph.

Genomes.io employs 14 people and is the second company that de Pape and co-founder Mark Hanel are in together. The developers met while working at MacMillan Publishers, and de Pap followed Hahnel to Figshare, a company that provides research data infrastructure to large government clients, which Hahnel launched in 2011.

In 2018, ahead of gene mapping developments that reduced the cost of genetic paving from billions to hundreds of dollars, De Pap, Hanel and three others founded Genomes.io. The following year, the company was accepted into the ConsenSys Ventures Tachyon 2.0 accelerator. It held an initial coin offering (ICO) in 2021.

Genomes.io sequences the genome of customers, encrypts them and stores them in an electronic safe. Clients can join in receiving reports based on their genetic information, such as origin and status of rare disease carriers, with a variety of new topics planned to come.

Clients can also allow the use of their data in research queries. Query matching takes place inside the data vault so that the genomic data never leaves the vault. Blockchain technology provides security by registering all queries to the data of holders of one version of the ledger.

Holders who decide to share genomic information are rewarded with GENE, as are those who contribute to the development or design of the project through the Distributed Autonomous Organization (DAO). GNOME is used for management and is available on the Sushi Exchange. The Geneticats NFT, available on OpenSea, offers genomic flooring and GENE / GNOME hybrid benefits.

The barrier to participation in DAO is low. “There is a lovely interest from people who wanted a closer relationship with the company,” de Papa said. Participants receive awards for contributing ideas to development and design. DAO has no “thing aside”, which includes large-scale projects with partners in Australia, Bermuda and the United States.

Makes one biometrics better

DNAVerse based in Madrid has found another fairly practical use for genomics. The company will use genetic information to confirm the identity of the holders as humans – as opposed to artificial intelligence or chatbots – across meteors. In collaboration with its sister organization, 3DforScience, DNAVerse creates NFTs “DNArt” that can be used similarly to avatars.

DNAVerse, according to marketing director Juan Castillo, is in the presale phase. It has eight employees and it shares several more employees with 3DforScience. She recently partnered with Polygon Studios and opened an embassy in the Matrix World meteor shower. The company will embed 200 “cryptoprotein” NFTs and 3,200 “DNArt” NFTs that are customizable based on customers’ genetic data but do not contain their data.

After the embedding of all “DNArt” NFTs, new customers will be required to select “Cryptoprotein” and “DNArt” held in a distributed market, with holders receiving a percentage of the price for their participation in the replication process. Their genetic data will be passed on to customers, who will remain in control of their data and have the option to remain anonymous. They will be collected under the management of an undeveloped DAO.

There are many club aspects to the business model. A clothing line is planned that includes the “DNArt”, welfare channels and virtual events based on genetic affinity. Customers can get “DNAat” for their pets as well.